Literature DB >> 8670795

Neuroserpin, an axonally secreted serine protease inhibitor.

T Osterwalder1, J Contartese, E T Stoeckli, T B Kuhn, P Sonderegger.   

Abstract

We have identified and chromatographically purified an axonally secreted glycoprotein of CNS and PNS neurons. Several peptides derived from it were microsequenced. Based on these sequences, a fragment of the corresponding cDNA was amplified and used as a probe to isolate a full length cDNA from a chicken brain cDNA library. Because the deduced amino acid sequence qualified the protein as a novel member of the serpin family of serine protease inhibitors, we called it neuroserpin. Analysis of the primary structural features further characterized neuroserpin as a heparin-independent, functional inhibitor of a trypsin-like serine protease. In situ hybridization revealed a predominantly neuronal expression during the late stages of neurogenesis and in the adult brain in regions which exhibit synaptic plasticity. Thus, neuroserpin might function as an axonally secreted regulator of the local extracellular proteolysis involved in the reorganization of the synaptic connectivity during development and synapse plasticity in the adult.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670795      PMCID: PMC450235     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  The development of the chick optic tectum. II. Autoradiographic studies.

Authors:  J H LaVail; W M Cowan
Journal:  Brain Res       Date:  1971-05-21       Impact factor: 3.252

2.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Axonal proteins of presynaptic neurons during synaptogenesis.

Authors:  P Sonderegger; M C Fishman; M Bokoum; H C Bauer; P G Nelson
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

5.  Plasminogen activator secretion by granule neurons in cultures of developing cerebellum.

Authors:  A Krystosek; N W Seeds
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

7.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

8.  The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.

Authors:  M N Blackburn; R L Smith; J Carson; C C Sibley
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

9.  Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation.

Authors:  Z Qian; M E Gilbert; M A Colicos; E R Kandel; D Kuhl
Journal:  Nature       Date:  1993-02-04       Impact factor: 49.962

10.  A few axonal proteins distinguish ventral spinal cord neurons from dorsal root ganglion neurons.

Authors:  P Sonderegger; M C Fishman; M Bokoum; H C Bauer; E A Neale; P G Nelson
Journal:  J Cell Biol       Date:  1984-01       Impact factor: 10.539

View more
  52 in total

1.  Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats.

Authors:  Z G Zhang; M Chopp; A Goussev; D Lu; D Morris; W Tsang; C Powers; K L Ho
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies.

Authors:  Giovanna Galliciotti; Markus Glatzel; Jochen Kinter; Serguei V Kozlov; Paolo Cinelli; Thomas Rülicke; Peter Sonderegger
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

3.  Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation.

Authors:  Mathias Gelderblom; Melanie Neumann; Peter Ludewig; Christian Bernreuther; Susanne Krasemann; Priyadharshini Arunachalam; Christian Gerloff; Markus Glatzel; Tim Magnus
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

4.  The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing.

Authors:  R H Adams; M Lohrum; A Klostermann; H Betz; A W Püschel
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

5.  Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury.

Authors:  I A Scarisbrick; M D Towner; P J Isackson
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

6.  Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.

Authors:  R M Hill; P K Parmar; L C Coates; E Mezey; J F Pearson; N P Birch
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

7.  Identification of a novel targeting sequence for regulated secretion in the serine protease inhibitor neuroserpin.

Authors:  Shoji Ishigami; Maria Sandkvist; Foon Tsui; Elizabeth Moore; Timothy A Coleman; Daniel A Lawrence
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

8.  The aggregation-prone intracellular serpin SRP-2 fails to transit the ER in Caenorhabditis elegans.

Authors:  Richard M Silverman; Erin E Cummings; Linda P O'Reilly; Mark T Miedel; Gary A Silverman; Cliff J Luke; David H Perlmutter; Stephen C Pak
Journal:  Genetics       Date:  2015-03-18       Impact factor: 4.562

9.  Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis.

Authors:  Hsin-I Ma; Chung-Lan Kao; Yi-Yen Lee; Guang-Yuh Chiou; Lung-Kuo Tai; Kai-Hsi Lu; Chi-Shuan Huang; Yi-Wei Chen; Shih-Hwa Chiou; Ing-Chan Cheng; Tai-Tong Wong
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

Review 10.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.